TradingView alternatives
TradingView is world-class for charts.
Its screener is a secondary feature.
TradingView's screener lacks fundamental depth for European small caps, restricts filter combinations on lower plans, and is not the core product. If filtering drives your workflow more than charting does, you are paying for the wrong tool. Below are the real screening alternatives.
Updated June 2026 · 5 alternatives reviewed
What a screening-first tool gives you
Dedicated screener
Screening is not a secondary tab in ScreenerHero — it is the entire product. Every design decision optimizes for filter-driven, multi-market screening.
European microcaps
TradingView fundamental coverage for European small and microcap names is inconsistent. ScreenerHero covers all European exchanges including illiquid names.
Fundamental depth
P/E, P/B, ROE, EV/EBITDA, margins, beta, and dividend yield — available across US, Canadian, and European equities with no plan restrictions on filter combinations.
Free and no signup
The core screener is free with no account required. Pro is €29/month — less than TradingView Essential at $14.95/month for a fraction of the screening value TradingView provides.
What to look for in a TradingView alternative for screening
Screening as the core product
Does the tool exist to screen, or does it bolt a screener onto a charting or news platform? The UX quality is night and day.
European fundamental coverage
P/E, ROE, and margins for European small caps — are they populated, or are most fields blank? Gap transparency matters.
Unrestricted filter combinations
Can you combine any filters freely, or does the plan gate certain columns or combinations? TradingView gates these heavily.
Dense table output
Results should be a sortable, dense table you can scan at speed — not cards, not paginated lists, not charts.
Price relative to use
If 80% of your time is in the screener, you should not be paying for a charting platform. Match the cost to what you actually use.
The 5 best TradingView alternatives for screening (2026)
ScreenerHero
Screening-first. US + Canada + all of Europe. Free core.
ScreenerHero is built around the screener — it is not a secondary feature. Filter by fundamentals across US, Canadian, and European equities in a single dense table. European microcaps and illiquid names are included. Free core screener with no signup. Pro at €29/month — $10–30 less than TradingView plans, with better fundamental coverage for European names.
Markets
US, Canada, BME, Euronext Paris, XETRA, Borsa Italiana — all European exchanges
Screener filters
P/E, P/B, ROE, EV/EBITDA, margins, beta, momentum, dividend yield
UI style
Desktop-first, data-dense, screening-first
Heatmap
Yes
MarketScreener
Broadest European fundamental database, news-first UX
One of the deepest European fundamental databases available. The product is built around analyst reports and news — screening is a secondary workflow and the UX is dated. A good reference for European data, but not a replacement for a screening-first tool.
Markets
Europe and global
Screener filters
300–600 fundamental filters, analyst estimates
UI style
Table-based, news-oriented, slow
Heatmap
No
Stockopedia
Score-driven research — Europe only, expensive
StockRanks (quality, value, momentum composite) is well-regarded for UK equities. Coverage of continental European microcaps has gaps. No Canadian equities. At €80/month for US + Europe, it is expensive for what it covers.
Markets
UK-weighted, some continental Europe (no Canada)
Screener filters
StockRanks composite + custom filters
UI style
Card-based, narrative focus
Heatmap
No
Finviz
Best dense screener for US equities — no real European coverage
The benchmark for dense screener UX. If TradingView frustrates you for screening, Finviz is the right reference point — but it covers US equities only. European exchanges are not meaningfully supported. At $39.50/month it is more expensive than ScreenerHero for narrower coverage.
Markets
US primarily
Screener filters
P/E, P/B, ROE, margins, momentum — US only
UI style
Desktop-first, data-dense
Heatmap
Yes
Stock Unlock
Budget-friendly global coverage, beginner-friendly interface
Broad coverage at an aggressive price point. Not built for dense, filter-driven screening — the interface is designed for visual stock exploration, not systematic multi-criteria screening. Useful if budget is the primary constraint.
Markets
100k+ stocks, 70+ exchanges including Europe
Screener filters
Basic fundamentals — not filter-dense
UI style
Visual, beginner-friendly
Heatmap
No
Quick comparison
| ScreenerHero | MarketScreener | Stockopedia | Finviz | Stock Unlock | |
|---|---|---|---|---|---|
| US coverage | |||||
| Canadian coverage | |||||
| European coverage | |||||
| Microcap coverage | |||||
| Dedicated screener | |||||
| Dense table UI | |||||
| Heatmap | |||||
| Free core features | |||||
| No account required | |||||
| Price/mo (from) | €29 | $30 | €60 | $39.50 | $7.50 |
Recommendation by use case
You screen more than you chart — across US, Canada, and Europe
ScreenerHero — built for this exactly, at €29/mo with full EU microcap coverage.
You need charts and screening in equal measure
TradingView — the charting is genuinely unmatched; accept the screener limitations.
You want the deepest European fundamental database available
MarketScreener — difficult UX, but the EU data depth is hard to beat.
You prefer composite score-driven research over raw filters
Stockopedia — if €60–80/month is acceptable and you focus on UK equities.
You screen US stocks only and want maximum density
Finviz — the benchmark for dense US screening, at $39.50/month.
The screener TradingView never built.
Dense tables. Fast filters. Heatmap. US, Canadian, and European stocks — including microcaps — in one screening-first tool. Free, no account needed. Pro at €29/month.